Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. APUS
APUS logo

APUS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

APUS News

Apimeds and Lōkahi Secure FDA Meeting Confirmation for LT-100

Feb 11 2026Newsfilter

Three Small IPOs Set to Raise $46 Million Next Week

Dec 23 2025renaissancecapital

E.F. Hutton Facilitates APUS and Mindwave Merger with $100 Million PIPE Financing

Dec 17 2025Globenewswire

E.F. Hutton Facilitates $100M Merger Between Apimeds and Mindwave Innovations

Dec 17 2025Newsfilter

Apimeds Closes $100 Million PIPE Financing to Advance Non-Opioid Therapies

Dec 10 2025Newsfilter

Apimeds Merges with MindWave, Secures Up to $100 Million Financing

Dec 01 2025Newsfilter

Apimeds Merges with MindWave to Create a Dual-Growth Biotech and Digital Asset Enterprise

Dec 01 2025Businesswire

Apimeds Expands ai² Future Labs Initiative to Involve University of San Diego Students in Biotech Business Development

Sep 15 2025Newsfilter

Apimeds Embraces FDA Draft Guidance as a Driver for Progressing Apitox Non-Opioid Pain Initiative

Sep 12 2025Newsfilter

Apimeds Pharmaceuticals US, Inc. Collaborates with University of Alabama to Enhance Biotech Business Development through ai² Future Labs

Aug 25 2025Newsfilter

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

Jul 15 2025Newsfilter